We are a leading global contract research organization providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic, non-profit and government organizations. We apply innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the development of safe and effective therapeutics and maximize the returns on their research and development investments. We have been in the drug development business for more than 25 years. Our development services include preclinical drug discovery services, programs, Phase I through Phase IV clinical development services and post-approval services, as well as bioanalytical, cGMP, global central laboratory and vaccines and biologics laboratory services. We have extensive clinical trial experience including regional, national and global studies across a wide spectrum of therapeutic areas and in over 100 countries, spanning six continents. In addition, for marketed drugs, biologics and devices, we offer support such as medical information, patient compliance programs, patient and disease registry programs, product safety and pharmacovigilance, standard response document development, observational studies, Phase IV monitored studies and prescription-to-over-the-counter, or Rx to OTC, programs. Our services offer our clients a way to identify and develop drug candidates more quickly and cost-effectively.
Company profile
Ticker
PPDI
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Syneos Health • Icon • Medpace • Incyte • Zymergen • OmniAb ...
Former names
Pharmaceutical Product Development Inc
SEC CIK
Corporate docs
IRS number
561640186
Latest filings (excl ownership)
CT ORDER
Confidential treatment order
18 Feb 14
CT ORDER
Confidential treatment order
16 Dec 13
15-12G
Securities registration termination
15 Dec 11
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Dec 11
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Dec 11
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Dec 11
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Dec 11
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Dec 11
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Dec 11
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Dec 11